Valuation: Genpharmasec Limited

Market Cap 432M 4.52M 3.9M 3.67M 3.33M 6.27M 6.37M 42.95M 16.79M 216M 16.96M 16.59M 719M P/E 2024
-545x
P/E 2025 94.5x
Enterprise Value 422M 4.42M 3.82M 3.59M 3.26M 6.13M 6.23M 42.02M 16.43M 212M 16.59M 16.23M 703M EV / Sales 2024
3.47x
EV / Sales 2025 2.96x
Free-Float
56.99%
Yield 2024 *
-
Yield 2025 -
1 day+0.98%
1 week-1.90%
Current month-0.96%
1 month+0.98%
3 months-9.65%
6 months-20.16%
Current year-21.37%
1 week 1
Extreme 1
1.06
1 month 0.99
Extreme 0.99
1.08
Current year 0.75
Extreme 0.75
1.45
1 year 0.75
Extreme 0.75
2.15
3 years 0.75
Extreme 0.75
8.71
5 years 0.75
Extreme 0.75
11.08
10 years 0.75
Extreme 0.75
18
Manager TitleAgeSince
Director of Finance/CFO 39 2022-10-31
Compliance Officer - 2024-03-26
Director TitleAgeSince
Director/Board Member 57 2019-01-01
Director/Board Member 58 2019-01-01
Director/Board Member - 2022-10-31
Change 5-day change 1-year change 3-year change Capi.($)
+0.98%-1.90%-49.26%-71.55% 5.91M
-0.02%+3.19%-15.56%+6.43% 193B
+0.76%+4.72%-1.88%+11.89% 117B
+1.43%-2.07%+7.17%+70.56% 59.89B
-1.18%+0.25%+34.12%+70.43% 56.01B
+0.79%+3.70%-6.40%-33.73% 49.96B
-1.89%+5.90%+10.87%-19.26% 33.87B
+0.45%+1.45% - - 31.36B
-1.76%+1.94%-5.85%+27.82% 24.77B
+0.94%-1.31%+41.93%-12.09% 24.59B
Average +0.04%+2.84%+1.68%+5.61% 58.98B
Weighted average by Cap. +0.12%+3.34%+0.11%+15.85%

Financials

2024 2025
Net sales 304M 3.18M 2.75M 2.58M 2.35M 4.41M 4.49M 30.24M 11.82M 152M 11.94M 11.68M 506M 337M 3.53M 3.05M 2.86M 2.6M 4.89M 4.97M 33.54M 13.11M 169M 13.24M 12.95M 561M
Net income -1.26M -13.15K -11.35K -10.67K -9.7K -18.24K -18.54K -125K -48.88K -629K -49.35K -48.28K -2.09M 12.31M 129K 111K 105K 95.04K 179K 182K 1.22M 479K 6.17M 483K 473K 20.49M
Net Debt -179M -1.87M -1.62M -1.52M -1.38M -2.6M -2.64M -17.79M -6.96M -89.57M -7.02M -6.87M -298M -9.4M -98.33K -84.93K -79.81K -72.58K -136K -139K -935K -366K -4.71M -369K -361K -15.65M
Logo Genpharmasec Limited
Genpharmasec Limited is an India-based company, which is engaged in the distribution of diagnostic pharma equipment and trading of securities. The Company’s segments include Pharmaceuticals, Trading in Securities, and Laboratory Testing. The Trading in Securities segment invests in the secondary securities market. The Company holds rights to the distribution of equipment, such as i-STAT Analyzers and its Cartridges, manufactured by Abbott Point of Care, USA, all over India. The i-STAT Analyzer is a blood analyzer used in Intensive Care Units (ICUs) of hospitals and provides test results in approximately 10 minutes. The Company’s wholly owned subsidiary includes M/s. Clinigenome India Private Limited.
Employees
10
Date Price Change Volume
26-08-17 1.030 +0.98% 73,408
26-08-14 ₹1.020 0.00% 220,955
26-08-13 ₹1.020 0.00% 180,519
26-08-12 ₹1.020 -1.92% 419,576
26-08-11 ₹1.040 -0.95% 462,674
  1. Stock Market
  2. Stocks
  3. ADIRASA Stock